Sequencing and medical services in the US
Molecular Health will no longer provide its end-to-end cancer diagnostic medical services in the US and thus will terminate processing patient cases effective August 19, 2016. In order to honor our turn-around time commitments, we will not be accepting any new patient cases after July 29, 2016.
In the future, Molecular Health will be focusing its efforts to further develop its information solutions for clinical decision support in oncology and drug safety, MH Guide™ and MH Effect™, and its Dataome technology platform.
We appreciate the opportunity to have provided sequencing and medical services to you in the US. Please let us know if you have any related questions by phone at Phone: +1 855-864-0164 or email customercareUS@molecularhealth.com.